Schedule 13D ownership disclosure
CHECKPOINT THERAPEUTICS INC
Common Stock, $0.0001 Par Value · CUSIP: 162828206
Event date: 2025-03-09
- Filing-level shares
- 6,922,249.00
- Percent of class
- 11.2%
- Fortress Biotech, Inc.Reported CIK 0001429260
Shares: 6,922,249.00 · Class: 11.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-022575
- Form type
- SCHEDULE 13D/A
- Filer
- Checkpoint Therapeutics, Inc.
- CIK
- CIK 1651407
- Filed
- Mar 11, 2025
- Reporting period
- Mar 09, 2025
- Description
- Schedule 13D beneficial ownership